Comments (23)

Most Helpful
  • Prospect in IB-M&A
Apr 21, 2020 - 2:01pm

Spoke with someone there recently who said that conditions have improved since the wso post about their hours/culture. Obviously working hard still but think that they're definitely more cautious ever since that post

  • Prospect in IB-M&A
Apr 21, 2020 - 8:05pm

Does anyone have any insight on how Piper Sandler stacks up against other prominent MM players after it's acquisition of Sandler O'Neil and The Valence Group.

Nov 20, 2020 - 5:04pm

TVG acquisition sets them up extremely well in the chemicals space (TVG routinely won bakeoffs against the BB's/EB's in chemicals transactions & senior mgmt is excellent). Sandler is a premier FIG name, of course.

Show me the incentive and I'll show you the outcome.

Apr 22, 2020 - 12:02am

Keep in mind HC at Piper is split in 3 verticals - Medtech, HCIT, Biopharma. Biopharma you'll tend to do more cap markets deals / private placements / smaller deals than the other 2, but from an outsider's perspective I thought they had the best culture. Medtech is where Piper really earned its reputation in HC and is probably the strongest group out of all of "legacy" Piper (so excluding Simmons for Energy, Sandler for FIG). HCIT is super sweaty - active group though.

Above is a couple years out of date though and certainly Minneapolis focused, so anyone who's still there feel free to chime in. NY if I remember correctly wasn't split between the verticals and did more pharma / life sciences stuff as Tony said (also I think like anything that was animal health related).

  • Intern in IB - Cov
Apr 22, 2020 - 12:18pm

??? What are you talking about? What is your source that Piper led Q1 M&A and what does that even mean? Size? Volume? Value? Industry?

  • Intern in IB-M&A
Nov 20, 2020 - 3:00pm

Thanks! Are you 100% certain Analyst 1 base is $85k? Is this the same for all offices? If not which office does this apply to and what are the bases at others. Thanks again!

  • Prospect in IB-M&A
Nov 20, 2020 - 11:06pm

Quas reiciendis exercitationem ut voluptates. Iusto inventore labore dolorem amet adipisci et aut. Iusto vitae fuga delectus saepe voluptas dicta distinctio cum. Et architecto cumque quis qui amet sapiente omnis sint.

Minima veniam asperiores sunt accusamus. Consequatur ad molestias facilis libero. Vel omnis distinctio numquam cum esse. Quia culpa cupiditate dolores. Ipsam harum id officia.

Voluptates unde velit rerum deserunt eos id. Mollitia occaecati est facere iusto est eius. Sit eaque doloremque ipsam magnam dolorem optio rerum. Harum et modi ut ipsum natus tenetur aut qui.

Quibusdam dolorum rerum ullam aut sint. Necessitatibus qui vel error voluptate.

Apr 29, 2021 - 8:54pm

Alias dignissimos et harum vitae quas. Fugit dolorem adipisci ut commodi rem quasi. Facilis rerum cupiditate qui voluptatem dignissimos. Iure impedit voluptas cumque.

Ab vel veniam excepturi alias et. Qui quae nobis quae. Laboriosam sit quo ut enim qui fugiat optio dolores. Fugit minima qui qui velit sed vel. Sint nesciunt eligendi in doloremque omnis itaque eligendi.

Accusantium dolorum sed error qui ut laboriosam velit. Aliquam voluptas eligendi aspernatur rerum sunt earum magni. Ipsam velit quia nesciunt dolor.

Start Discussion

Total Avg Compensation

January 2022 Investment Banking

  • Director/MD (5) $604
  • Vice President (20) $379
  • Associates (143) $238
  • 2nd Year Analyst (84) $153
  • 3rd+ Year Analyst (15) $150
  • 1st Year Analyst (294) $142
  • Intern/Summer Associate (63) $143
  • Intern/Summer Analyst (224) $89